UNSPSC 51452005: Bunamidine hydrochloride

This classification denotes an antihelminthic agent with the molecular formula C25H38N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y80LB0Q7CB, chemically known as 1-naphthamidine, n,n-dibutyl-4-hexyloxy-, monohydrochloride but more generally known as bunamidine hydrochloride, which bears US NIH Compound Identifier 13985. Most nations, for tariff and trade purposes, schedule bunamidine hydrochloride under HS 29252900 and SITC 51482. As of Q4 2014, BUNAMIDINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Bunamidine hydrochloride bears US NLM identifiers UMLS ID C0141753 and NCI Concept Code C75211. SMILES: CCCCCCOC1CCC(C2C1CCCC2)C(=N)N(CCCC)CCCC.CL.

UNSPSC 51452005 Bunamidine hydrochloride is a Commodity code that in practice covers pharmaceutical products and medical supplies state and local governments procure for community health, emergency response, and pharmacy benefit programs. Recent solicitations show state and local buyers actually purchasing naloxone and drug deactivation systems for public health initiatives, medical and first aid supplies for fire departments, and generic pharmaceuticals and OTC products through cooperative purchasing arrangements, with little specificity around the bunamidine compound itself in current procurement activity. Issuing bodies include county health departments (Seminole County, Florida), municipal purchasing offices (City of Tampa), state health and human services agencies (Texas HHS Commission), and regional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The code spans a broad range of health and safety product categories, from emergency medical supplies to wholesale pharmacy distribution channels, rather than a single drug product.

Recent activity concentrates in Florida and Texas, with cooperative purchasing reaching across multiple states including Minnesota and Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with a response deadline of July 26, 2023, and a two-year initial term plus one-year renewal option. The City of Tampa Purchasing Department solicited sealed bids (26P00145) on March 25, 2026, for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with a March 13, 2026 response deadline and an estimated contract amount of $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Department of Administration issued RFP S1070000015802 on January 20, 2026, through MMCAP for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026, and a two-year contract term effective July 1, 2026. The Texas HHS Commission posted RFI HHS0017013 on April 3, 2026, to explore direct-to-manufacturer prescription fulfillment capabilities, signaling potential future procurement in pharmacy benefit management.